Global Autologous Cell Therapy Market Report By Therapy (Autologous Stem Cell Therapy, Autologous Cellular Immunotherapies), By Application (Oncology, Musculoskeletal Disorder, Blood Disorder, Autoimmune Disease, Others), By Source (Bone Marrow, Epidermis, Others), By End User (Hospitals, Research Centers, Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11212590
April 2021
Report Formats:
The global demand for Autologous Cell Therapy Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
 
Autologous cell therapy (ACT) is a novel therapy that uses an individual’s cells to treat various diseases. The therapy utilizes the patient’s cells, which are cultured outside the body, the cell number is expanded in-vitro and reintroduced to the body. The therapy assures reduced side effects, reduced the risk of bio-incompatibility, disease transmission associated with graft, and systemic immunological reactions and disease. The therapy can be of two types; autologous stem cell therapy and autologous cellular immune therapies. The cells from bone marrow epidermis or other sources are utilized for cell culture and expansion. Autologous therapy is applied in the treatment of cancers, musculoskeletal disorders, blood disorders, and cosmetic treatments. Hospitals and research centers are increasing the use of autologous therapy to treat patients.
 
Market Dynamics
 
The growing prevalence of cancer, neurological disorders, and autoimmune diseases are the prime factors that are driving the autologous therapy market. The factors such as reduced side effects and reduced risk of transmission of other diseases are fuelling the market. Moreover, increasing R & D in cell culture, and government initiatives in novel innovative therapies is uplifting the global market. During the global pandemic COVID-19, the autologous therapy market is expected to experience steady but inclining growth owing to the growing overall healthcare market along with rising R & D in cell culture therapies.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of autologous cell therapy.
 
Market Segmentation
 
The entire autologous cell therapy market has been sub-categorized into therapy, application, source and end-user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Therapy
  • Autologous Stem Cell Therapy
  • Autologous Cellular Immunotherapies
 
By Application
  • Oncology
  • Musculoskeletal Disorder
  • Blood Disorder
  • Autoimmune Disease
  • Others
 
By Source
  • Bone Marrow
  • Epidermis
  • Others
 
By End User
  • Hospitals
  • Research Centers
  • Others
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for autologous cell therapy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Global Autologous Cell Therapy Market Share by Region (Representative Graph)
 
Global Autologous Cell Therapy Market Share
 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the autologous cell therapy market include Vericel Corporation, Pharmicell Co., Inc., Holostem Terapie Avanzate S.r.l., Lineage Cell Therapeutics, Inc., Opexa Therapeutics, BrainStorm Cell Therapeutics, Sangamo Therapeutics. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                          
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Autologous Cell Therapy Market
       2.2. Global Autologous Cell Therapy Market Snapshot
 
3 . AUTOLOGOUS CELL THERAPY – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Autologous Cell Therapy Market
       3.3. Market Restraints of Autologous Cell Therapy Market
       3.4. Opportunities of Autologous Cell Therapy Market
       3.5. Trends of Autologous Cell Therapy Market
       3.6. Porter’s Five Force Analysis of Autologous Cell Therapy Market
       3.7. Autologous Cell Therapy Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Therapy
           3.7.2 Market Attractive Analysis by Application
           3.7.3 Market Attractive Analysis by Source
           3.7.4 Market Attractive Analysis by End User
           3.7.5 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Autologous Cell Therapy Value Chain Analysis
       4.2. Autologous Cell Therapy Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Autologous Cell Therapy Raw Material Manufactures List
           4.2.3. Price Trend of Autologous Cell Therapy Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Autologous Cell Therapy Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Autologous Cell Therapy Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Autologous Cell Therapy Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Autologous Cell Therapy Market
 
6 . GLOBAL AUTOLOGOUS CELL THERAPY MARKET ANALYSIS BY THERAPY
       6.1 Overview by Therapy
       6.2 Global Autologous Cell Therapy Market Analysis by Therapy
       6.3 Market Analysis of Autologous Stem Cell Therapy by Regions
       6.4 Market Analysis of Autologous Cellular Immunotherapies by Regions
 
7 . GLOBAL AUTOLOGOUS CELL THERAPY MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Global Autologous Cell Therapy Market Analysis by Application
       7.3 Market Analysis of Oncology by Regions
       7.4 Market Analysis of Musculoskeletal Disorder by Regions
       7.5 Market Analysis of Blood Disorder by Regions
       7.6 Market Analysis of Autoimmune Disease by Regions
       7.7 Market Analysis of Others by Regions
 
8 . GLOBAL AUTOLOGOUS CELL THERAPY MARKET ANALYSIS BY SOURCE
       8.1 Overview by Source
       8.2 Global Autologous Cell Therapy Market Analysis by Source
       8.3 Market Analysis of Bone Marrow by Regions
       8.4 Market Analysis of Epidermis by Regions
       8.5 Market Analysis of Others by Regions
 
9 . GLOBAL AUTOLOGOUS CELL THERAPY MARKET ANALYSIS BY END USER
       9.1 Overview by End User
       9.2 Global Autologous Cell Therapy Market Analysis by End User
       9.3 Market Analysis of Hospitals by Regions
       9.4 Market Analysis of Research Centers by Regions
       9.5 Market Analysis of Others by Regions
 
10 . GLOBAL AUTOLOGOUS CELL THERAPY MARKET ANALYSIS BY GEOGRAPHY
       10.1. Regional Outlook
       10.2. Introduction
       10.3. North America
           10.3.1. Overview
           10.3.2. North America Autologous Cell Therapy Market Estimate by Country
           10.3.3. United State
           10.3.4. Rest of North America
       10.4. Europe
           10.4.1. Overview
           10.4.2. Europe Autologous Cell Therapy Market Estimate by Market Segment
           10.4.3. Europe Autologous Cell Therapy Market Estimate by Country
           10.4.4. United Kingdom
           10.4.5. France
           10.4.6. Germany
           10.4.7 Rest of Europe
       10.5. Asia Pacific
           10.5.1. Overview
           10.5.2. Asia Pacific Autologous Cell Therapy Market Estimate by Market Segment
           10.5.3. Asia Pacific Autologous Cell Therapy Market Estimate by Country
           10.5.4. China
           10.5.5. Japan
           10.5.6. India
           10.5.7. Rest of Asia Pacific
       10.6. Latin America
           10.6.1. Overview
           10.6.2. Latin America Autologous Cell Therapy Market Estimate by Market Segment
           10.6.3. Latin America Autologous Cell Therapy Market Estimate by Country
           10.6.4. Brazil
           10.6.5. Rest of Latin America
       10.7. Middle East & Africa
           10.7.1. Overview
           10.7.2. Middle East & Africa Autologous Cell Therapy Market Estimate by Market Segment
           10.7.3. Middle East & Africa Autologous Cell Therapy Market Estimate by Country
           10.7.4. Middle East
           10.7.5. Africa
 
11 COMPETITIVE LANDSCAPE OF THE AUTOLOGOUS CELL THERAPY COMPANIES
       11.1. Autologous Cell Therapy Market Competition
       11.2. Partnership/Collaboration/Agreement
       11.3. Merger And Acquisitions
       11.4. New Product Launch
       11.5. Other Developments
 
12 COMPANY PROFILES OF AUTOLOGOUS CELL THERAPY INDUSTRY
       12.1. Company Share Analysis
       12.2. Market Concentration Rate
       12.3. Vericel Corporation
           12.3.1. Company Overview
           12.3.2. Financials
           12.3.3. Products
           12.3.4. Recent Developments
       12.4. Pharmicell Co., Inc.
           12.4.1. Company Overview
           12.4.2. Financials
           12.4.3. Products
           12.4.4. Recent Developments
       12.5. Holostem Terapie Avanzate S.r.l.
           12.5.1. Company Overview
           12.5.2. Financials
           12.5.3. Products
           12.5.4. Recent Developments
       12.6. Lineage Cell Therapeutics, Inc.
           12.6.1. Company Overview
           12.6.2. Financials
           12.6.3. Products
           12.6.4. Recent Developments
       12.7. Opexa Therapeutics
           12.7.1. Company Overview
           12.7.2. Financials
           12.7.3. Products
           12.7.4. Recent Developments
       12.8. BrainStorm Cell Therapeutics
           12.8.1. Company Overview
           12.8.2. Financials
           12.8.3. Products
           12.8.4. Recent Developments
       12.9. Sangamo Therapeutics
           12.9.1. Company Overview
           12.9.2. Financials
           12.9.3. Products
           12.9.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Autologous Cell Therapy Market Snapshot
  • Drivers of The Global Autologous Cell Therapy Market Impact Analysis
  • Restraints of The Global Autologous Cell Therapy Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Autologous Cell Therapy Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Autologous Cell Therapy Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Autologous Cell Therapy Market
  • Global Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Autologous Stem Cell Therapy by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Autologous Cellular Immunotherapies by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis by Application (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Oncology by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Musculoskeletal Disorder by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Blood Disorder by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Autoimmune Disease by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Others by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis by Source (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Bone Marrow by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Epidermis by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Others by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis by End User (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Hospitals by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Research Centers by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Others by Geography (USD MN)
  • Global Autologous Cell Therapy Market by Geography (USD MN)
  • North America Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • North America Autologous Cell Therapy Market Estimate by Application (USD MN)
  • North America Autologous Cell Therapy Market Estimate by Source (USD MN)
  • North America Autologous Cell Therapy Market Estimate by End User (USD MN)
  • North America Autologous Cell Therapy Market Estimate by Country (USD MN)
  • United State Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • United State Autologous Cell Therapy Market Estimate by Application (USD MN)
  • United State Autologous Cell Therapy Market Analysis by Source (USD MN)
  • United State Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Rest of North America Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Rest of North America Autologous Cell Therapy Market Estimate by Application (USD MN)
  • Rest of North America Autologous Cell Therapy Market Estimate by Source(USD MN)
  • Rest of North America Autologous Cell Therapy Market Estimate by End User(USD MN)
  • Europe Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Europe Autologous Cell Therapy Market Estimate by Application (USD MN)
  • Europe Autologous Cell Therapy Market Estimate by Source (USD MN)
  • Europe Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Europe Autologous Cell Therapy Market Estimate by Country (USD MN)
  • United Kingdom Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • United Kingdom Autologous Cell Therapy Market Estimate by Application (USD MN)
  • United Kingdom Autologous Cell Therapy Market Estimate by Source (USD MN)
  • United Kingdom Autologous Cell Therapy Market Estimate by End User (USD MN)
  • France Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • France Autologous Cell Therapy Market Estimate by Application (USD MN)
  • France Autologous Cell Therapy Market Estimate by Source (USD MN)
  • France Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Germany Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Germany Autologous Cell Therapy Market Estimate by Application (USD MN)
  • Germany Autologous Cell Therapy Market Estimate by Source (USD MN)
  • Germany Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Rest of Europe Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Rest of Europe Autologous Cell Therapy Market Estimate by Application (USD MN)
  • Rest of Europe Autologous Cell Therapy Market Estimate by Source (USD MN)
  • Rest of Europe Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Asia Pacific Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Asia Pacific Autologous Cell Therapy Market Estimate by Application (USD MN)
  • Asia Pacific Autologous Cell Therapy Market Estimate by Source (USD MN)
  • Asia Pacific Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Asia Pacific Autologous Cell Therapy Market Estimate by Country (USD MN)
  • China Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • China Autologous Cell Therapy Market Estimate by Application (USD MN)
  • China Autologous Cell Therapy Market Estimate by Source (USD MN)
  • China Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Japan Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Japan Autologous Cell Therapy Market Estimate by Application (USD MN)
  • Japan Autologous Cell Therapy Market Estimate by Source (USD MN)
  • Japan Autologous Cell Therapy Market Estimate by End User(USD MN)
  • India Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • India Autologous Cell Therapy Market Estimate by Application (USD MN)
  • India Autologous Cell Therapy Market Estimate by Source (USD MN)
  • India Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Rest of Asia Pacific Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Rest of Asia Pacific Autologous Cell Therapy Market Estimate by Application (USD MN)
  • Rest of Asia Pacific Autologous Cell Therapy Market Estimate by Source (USD MN)
  • Rest of Asia Pacific Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Latin America Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Latin America Autologous Cell Therapy Market Estimate by Application (USD MN)
  • Latin America Autologous Cell Therapy Market Estimate by Source (USD MN)
  • Latin America Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Latin America Autologous Cell Therapy Market Estimate by Country (USD MN)
  • Brazil Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Brazil Autologous Cell Therapy Market Estimate by Application (USD MN)
  • Brazil Autologous Cell Therapy Market Estimate by Source (USD MN)
  • Brazil Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Rest of Latin America Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Rest of Latin America Autologous Cell Therapy Market Estimate by Application (USD MN)
  • Rest of Latin America Autologous Cell Therapy Market Estimate by Source (USD MN)
  • Rest of Latin America Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Middle East & Africa Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Middle East & Africa Autologous Cell Therapy Market Estimate by Application (USD MN)
  • Middle East & Africa Autologous Cell Therapy Market Estimate by Source (USD MN)
  • Middle East & Africa Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Middle East & Africa Autologous Cell Therapy Market Estimate by Country (USD MN)
  • Middle East Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Middle East Autologous Cell Therapy Market Estimate by Application (USD MN)
  • Middle East Autologous Cell Therapy Market Estimate by Source (USD MN)
  • Middle East Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Africa Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Africa Autologous Cell Therapy Market Estimate by Application (USD MN)
  • Africa Autologous Cell Therapy Market Estimate by Source (USD MN)
  • Africa Autologous Cell Therapy Market Estimate by End User (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Autologous Cell Therapy Report
  • Market Research Process
  • Market Research Methodology
  • Global Autologous Cell Therapy Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Therapy
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Source
  • Market Attractiveness Analysis by End User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Autologous Cell Therapy Market Analysis by Therapy (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Autologous Stem Cell Therapy by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Autologous Cellular Immunotherapies by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis by Application (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Oncology by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Musculoskeletal Disorder by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Blood Disorder by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Autoimmune Disease by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Others by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis by Source (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Bone Marrow by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Epidermis by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Others by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis by End User (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Hospitals by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Research Centers by Geography (USD MN)
  • Global Autologous Cell Therapy Market Analysis in Others by Geography (USD MN)
  • Latin America Autologous Cell Therapy Market by Revenue
  • Middle East & Africa Autologous Cell Therapy Market by Revenue
  • Recent Development in Autologous Cell Therapy Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials